Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).
Journal articles
- Letter
Gentry, JL; Mentz, RJ; Hurdle, M; Wang, A
Published in: J Am Coll Cardiol
October 18, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
October 18, 2016
Volume
68
Issue
16
Start / End Page
1815 / 1817
Location
United States
Related Subject Headings
- Ranolazine
- Pilot Projects
- Middle Aged
- Male
- Humans
- Female
- Dyspnea
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Cardiomyopathy, Hypertrophic
Citation
APA
Chicago
ICMJE
MLA
NLM
Gentry, J. L., Mentz, R. J., Hurdle, M., & Wang, A. (2016). Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME). J Am Coll Cardiol, 68(16), 1815–1817. https://doi.org/10.1016/j.jacc.2016.07.758
Gentry, James L., Robert J. Mentz, Melissa Hurdle, and Andrew Wang. “Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).” J Am Coll Cardiol 68, no. 16 (October 18, 2016): 1815–17. https://doi.org/10.1016/j.jacc.2016.07.758.
Gentry JL, Mentz RJ, Hurdle M, Wang A. Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME). J Am Coll Cardiol. 2016 Oct 18;68(16):1815–7.
Gentry, James L., et al. “Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).” J Am Coll Cardiol, vol. 68, no. 16, Oct. 2016, pp. 1815–17. Pubmed, doi:10.1016/j.jacc.2016.07.758.
Gentry JL, Mentz RJ, Hurdle M, Wang A. Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME). J Am Coll Cardiol. 2016 Oct 18;68(16):1815–1817.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
October 18, 2016
Volume
68
Issue
16
Start / End Page
1815 / 1817
Location
United States
Related Subject Headings
- Ranolazine
- Pilot Projects
- Middle Aged
- Male
- Humans
- Female
- Dyspnea
- Cardiovascular System & Hematology
- Cardiovascular Agents
- Cardiomyopathy, Hypertrophic